Cargando…

The role of FV 1691G>A, FII 20210G>A mutations and MTHFR 677C>T; 1298A>C and 103G>T FXIII gene polymorphisms in pathogenesis of intraventricular hemorrhage in infants born before 32 weeks of gestation

BACKGROUND: Congenital thrombophilia is associated with an increased intraventricular hemorrhage (IVH) risk among newborns, but it may also play a protective role. The role of genetic polymorphisms involved in the coagulation pathway of IVH pathogenesis is probably a consequence of an increased risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Szpecht, Dawid, Gadzinowski, Janusz, Seremak-Mrozikiewicz, Agnieszka, Kurzawińska, Grażyna, Drews, Krzysztof, Szymankiewicz, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496967/
https://www.ncbi.nlm.nih.gov/pubmed/28578513
http://dx.doi.org/10.1007/s00381-017-3460-8
_version_ 1783248072984231936
author Szpecht, Dawid
Gadzinowski, Janusz
Seremak-Mrozikiewicz, Agnieszka
Kurzawińska, Grażyna
Drews, Krzysztof
Szymankiewicz, Marta
author_facet Szpecht, Dawid
Gadzinowski, Janusz
Seremak-Mrozikiewicz, Agnieszka
Kurzawińska, Grażyna
Drews, Krzysztof
Szymankiewicz, Marta
author_sort Szpecht, Dawid
collection PubMed
description BACKGROUND: Congenital thrombophilia is associated with an increased intraventricular hemorrhage (IVH) risk among newborns, but it may also play a protective role. The role of genetic polymorphisms involved in the coagulation pathway of IVH pathogenesis is probably a consequence of an increased risk of thrombosis in the fine blood vessels in the germinal matrix region. MATERIAL AND METHODS: The aim of this study was to evaluate the possible relationship between Factor V (FV) 1691G>A, Factor II (FII) 20210G>A mutations and methylenetetrahydrofolate reductase (MTHFR) 677C>T; 1298A>C and Factor XIII (FXIII) 103G>T gene polymorphisms and the occurrence of IVH in 100 infants born from 24 + 0 to 32 + 0 weeks of gestation, born from singleton pregnancy, before 32 + 0 weeks of gestation, exposed to antenatal steroid therapy, and without congenital abnormalities. RESULTS: IVH developed 45 (45%) infants, including 15 (33.33%) diagnosed with IVH stage I, 20 (42.22%) with stage II, 8 (17.77%) with stage III, and 3 (6.66%) with stage IV. Analysis showed a prevalence 4.5 times higher of IVH stages II to IV in infants with the genotype CC (OR 4511 (1147–17.75); p = 0.026) of MTHFR 1298A>C gene polymorphism. Our investigation did not confirm any significant prevalence of IVH development in other studied mutations/polymorphisms. CONCLUSIONS: This study confirmed that the MTHFR 1298A>C polymorphism is associated with the risk of IVH. IVH is a significant problem for preterm infants. In addition to little progress in preventing IVH in preterm babies, substantial research that is focused on understanding the etiology, mechanism, and risk factors for IVH is imperative. In the era of personalized medicine, identification of genetic risk factors creates opportunities to generate preventative strategies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00381-017-3460-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5496967
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-54969672017-07-18 The role of FV 1691G>A, FII 20210G>A mutations and MTHFR 677C>T; 1298A>C and 103G>T FXIII gene polymorphisms in pathogenesis of intraventricular hemorrhage in infants born before 32 weeks of gestation Szpecht, Dawid Gadzinowski, Janusz Seremak-Mrozikiewicz, Agnieszka Kurzawińska, Grażyna Drews, Krzysztof Szymankiewicz, Marta Childs Nerv Syst Original Paper BACKGROUND: Congenital thrombophilia is associated with an increased intraventricular hemorrhage (IVH) risk among newborns, but it may also play a protective role. The role of genetic polymorphisms involved in the coagulation pathway of IVH pathogenesis is probably a consequence of an increased risk of thrombosis in the fine blood vessels in the germinal matrix region. MATERIAL AND METHODS: The aim of this study was to evaluate the possible relationship between Factor V (FV) 1691G>A, Factor II (FII) 20210G>A mutations and methylenetetrahydrofolate reductase (MTHFR) 677C>T; 1298A>C and Factor XIII (FXIII) 103G>T gene polymorphisms and the occurrence of IVH in 100 infants born from 24 + 0 to 32 + 0 weeks of gestation, born from singleton pregnancy, before 32 + 0 weeks of gestation, exposed to antenatal steroid therapy, and without congenital abnormalities. RESULTS: IVH developed 45 (45%) infants, including 15 (33.33%) diagnosed with IVH stage I, 20 (42.22%) with stage II, 8 (17.77%) with stage III, and 3 (6.66%) with stage IV. Analysis showed a prevalence 4.5 times higher of IVH stages II to IV in infants with the genotype CC (OR 4511 (1147–17.75); p = 0.026) of MTHFR 1298A>C gene polymorphism. Our investigation did not confirm any significant prevalence of IVH development in other studied mutations/polymorphisms. CONCLUSIONS: This study confirmed that the MTHFR 1298A>C polymorphism is associated with the risk of IVH. IVH is a significant problem for preterm infants. In addition to little progress in preventing IVH in preterm babies, substantial research that is focused on understanding the etiology, mechanism, and risk factors for IVH is imperative. In the era of personalized medicine, identification of genetic risk factors creates opportunities to generate preventative strategies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00381-017-3460-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-06-03 2017 /pmc/articles/PMC5496967/ /pubmed/28578513 http://dx.doi.org/10.1007/s00381-017-3460-8 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Paper
Szpecht, Dawid
Gadzinowski, Janusz
Seremak-Mrozikiewicz, Agnieszka
Kurzawińska, Grażyna
Drews, Krzysztof
Szymankiewicz, Marta
The role of FV 1691G>A, FII 20210G>A mutations and MTHFR 677C>T; 1298A>C and 103G>T FXIII gene polymorphisms in pathogenesis of intraventricular hemorrhage in infants born before 32 weeks of gestation
title The role of FV 1691G>A, FII 20210G>A mutations and MTHFR 677C>T; 1298A>C and 103G>T FXIII gene polymorphisms in pathogenesis of intraventricular hemorrhage in infants born before 32 weeks of gestation
title_full The role of FV 1691G>A, FII 20210G>A mutations and MTHFR 677C>T; 1298A>C and 103G>T FXIII gene polymorphisms in pathogenesis of intraventricular hemorrhage in infants born before 32 weeks of gestation
title_fullStr The role of FV 1691G>A, FII 20210G>A mutations and MTHFR 677C>T; 1298A>C and 103G>T FXIII gene polymorphisms in pathogenesis of intraventricular hemorrhage in infants born before 32 weeks of gestation
title_full_unstemmed The role of FV 1691G>A, FII 20210G>A mutations and MTHFR 677C>T; 1298A>C and 103G>T FXIII gene polymorphisms in pathogenesis of intraventricular hemorrhage in infants born before 32 weeks of gestation
title_short The role of FV 1691G>A, FII 20210G>A mutations and MTHFR 677C>T; 1298A>C and 103G>T FXIII gene polymorphisms in pathogenesis of intraventricular hemorrhage in infants born before 32 weeks of gestation
title_sort role of fv 1691g>a, fii 20210g>a mutations and mthfr 677c>t; 1298a>c and 103g>t fxiii gene polymorphisms in pathogenesis of intraventricular hemorrhage in infants born before 32 weeks of gestation
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496967/
https://www.ncbi.nlm.nih.gov/pubmed/28578513
http://dx.doi.org/10.1007/s00381-017-3460-8
work_keys_str_mv AT szpechtdawid theroleoffv1691gafii20210gamutationsandmthfr677ct1298acand103gtfxiiigenepolymorphismsinpathogenesisofintraventricularhemorrhageininfantsbornbefore32weeksofgestation
AT gadzinowskijanusz theroleoffv1691gafii20210gamutationsandmthfr677ct1298acand103gtfxiiigenepolymorphismsinpathogenesisofintraventricularhemorrhageininfantsbornbefore32weeksofgestation
AT seremakmrozikiewiczagnieszka theroleoffv1691gafii20210gamutationsandmthfr677ct1298acand103gtfxiiigenepolymorphismsinpathogenesisofintraventricularhemorrhageininfantsbornbefore32weeksofgestation
AT kurzawinskagrazyna theroleoffv1691gafii20210gamutationsandmthfr677ct1298acand103gtfxiiigenepolymorphismsinpathogenesisofintraventricularhemorrhageininfantsbornbefore32weeksofgestation
AT drewskrzysztof theroleoffv1691gafii20210gamutationsandmthfr677ct1298acand103gtfxiiigenepolymorphismsinpathogenesisofintraventricularhemorrhageininfantsbornbefore32weeksofgestation
AT szymankiewiczmarta theroleoffv1691gafii20210gamutationsandmthfr677ct1298acand103gtfxiiigenepolymorphismsinpathogenesisofintraventricularhemorrhageininfantsbornbefore32weeksofgestation
AT szpechtdawid roleoffv1691gafii20210gamutationsandmthfr677ct1298acand103gtfxiiigenepolymorphismsinpathogenesisofintraventricularhemorrhageininfantsbornbefore32weeksofgestation
AT gadzinowskijanusz roleoffv1691gafii20210gamutationsandmthfr677ct1298acand103gtfxiiigenepolymorphismsinpathogenesisofintraventricularhemorrhageininfantsbornbefore32weeksofgestation
AT seremakmrozikiewiczagnieszka roleoffv1691gafii20210gamutationsandmthfr677ct1298acand103gtfxiiigenepolymorphismsinpathogenesisofintraventricularhemorrhageininfantsbornbefore32weeksofgestation
AT kurzawinskagrazyna roleoffv1691gafii20210gamutationsandmthfr677ct1298acand103gtfxiiigenepolymorphismsinpathogenesisofintraventricularhemorrhageininfantsbornbefore32weeksofgestation
AT drewskrzysztof roleoffv1691gafii20210gamutationsandmthfr677ct1298acand103gtfxiiigenepolymorphismsinpathogenesisofintraventricularhemorrhageininfantsbornbefore32weeksofgestation
AT szymankiewiczmarta roleoffv1691gafii20210gamutationsandmthfr677ct1298acand103gtfxiiigenepolymorphismsinpathogenesisofintraventricularhemorrhageininfantsbornbefore32weeksofgestation